Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting

Clinical Respiratory Journal

Volumn 5, Issue 3, 2011, Pages 173-182

  Søes Petersen, Ulrik ^a   Kava, Tuomo ^b   Dahle, Ragnar ^c   Lei, Yao ^d   Dam, Nanna ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^c Astma og Allergiklinikken Vestsiden   (Norway)

^d ASTRAZENECA   (United Kingdom)

Author keywords

Asthma control; Budesonide formoterol maintenance and reliever therapy; Exacerbations; Real life

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; SMART; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DENMARK; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FINLAND; HUMAN; INTERMETHOD COMPARISON; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NORWAY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-ASTHMATIC AGENTS; ASTHMA; BUDESONIDE; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; ETHANOLAMINES; HUMANS; LUNG; MALE; MIDDLE AGED; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959330698     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2010.00217.x     Document Type: Article

References (21)

1. Global Initiative for Asthma. Global strategy for asthma management and prevention. Available at: (last accessed 30 June 2010).
2. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med. 1996;153: 1481-8.
3. Greening AP, Ind PW, Northfield M, Shaw G. Added salmetorol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet. 1994;344: 219-24.
4. Aubier M, Pieters WR, Schlösser NJJ, Steinmetz K-O. Salmeterol/fluticasone propionate (50/500mg) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthma. Respir Med. 1999;93: 876-84.
5. Pauwels RA, Löfdahl CG, Postma SD, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbationsof asthma. N Engl J Med. 1997;337: 1405-11.
6. Shapiro G, Lumry W, Wolfe J, Given J, White MV, Woodring A, Baitinger L, House K, Prillaman B, Shah T. Combined salmeterol 50mg and fluticasone propionate 250mg in the Diskus device for the treatment of asthma. Am J Respir Crit Care Med. 2000;161: 527-34.
7. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE, GOAL Investigators Group. Can guideline-defined asthma control be achieved? Am J Respir Crit Care Med. 2004;15(170): 836-44.
8. Rabe K, Pizzichini E, Ställberg B, Romero S, Balanzat AM, Attienza T, Lier P, Jorup C. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma. Chest. 2006;129: 246-56.
9. O'Byrne PM, Bisgaard H, Godard P, Pistolesi M, Palmqvist M, Zhu Y, Ekström T, Bateman E. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171: 129-36.
10. Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya P, Hultquist C. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin. 2004;20: 1403-18.
11. Rabe K, Atienza T, Magyar P, Larsson P, Jorup C, Lallo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006;368: 744-53.
12. Kuna P, Peters MJ, Manjra AI, Jorup C, Naya IP, Martinez-Jimenez NE, Buhl R. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract. 2007;61: 725-36.
13. Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med. 2007;101: 2437-46.
14. Vogelmeier C, D'Urzo A, Pauwels R, Merino JM, Jaspal M, Boutet S, Naya I, Price D. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J. 2005;26: 819-29.
15. Reddel J, Barned DJ. Pharmacological strategies for self-management of asthma exacerbation. Eur Respir J. 2006;28: 182-99.
16. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987;136: 225-44.
17. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report 2002.
18. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14: 902-7.
19. Juniper EF, Bousquet J, Abetz L, Bateman ED, GOAL Committee. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2006;100: 616-21.
20. Baiardini I, Braido F, Brandi S, Tarantini F, Bonini S, Bousquet PJ, Zuberbier T, Demoly P, Canonica GW. The impact of GINA suggested drugs for the treatment of asthma on health-releated quality of life: a GA(2)LEN review. Allergy. 2008;63: 1015-30.
21. Sears MR, Boulet LP, Laviolette M, Fitzgerald JM, Bai TR, Kaplan A, Smiljanic-Georgijev N, Lee JS. Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma. Eur Respir J. 2008;31: 982-9.